The "Intraoperative Radiation Therapy Market by Technology (Electron IORT, Brachytherapy), Products & Services (Accelerators, Treatment Planning system, Applicators, Afterloaders, Accessories), Application (Breast, Brain, Lung Cancer) - Global Forecasts to 2025" report has been added to ResearchAndMarkets.com's offering.
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period.
The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications are expected to offer lucrative growth opportunities to market players. However, the complex nature of technology coupled with a shortage of trained personnel and preference of conventional radiotherapy over IORT by physicians owing to reimbursement coverage are the major factors that are expected to restrain the growth of this market.
The system/accelerators segment is expected to account for the largest market share during the forecast period.
Based on product type, the intraoperative radiation therapy market products market is segmented into system/accelerators, treatment planning systems, applicators & after loaders, and accessories. The systems/accelerators segment is expected to account for the largest share of the IORT products market in 2019. The large share of this segment can be attributed to the low cost of accelerators as compared to advanced radiosurgery products, growing applications of IORT products in cancer treatment, and the development of technologically advanced mobile systems/accelerators.
The breast cancer segment is expected to hold the largest share of the intraoperative radiation therapy market, by application, during the forecast period.
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head and neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. The breast cancer segment is expected to account for the largest share of this market in 2019. The large share of this segment can be attributed to a high prevalence of breast cancer, coupled with advantages offered by IORT such as the reduced amount of irradiation, shorter treatment time, and lesser clinical risks.
Europe to account for the second-largest share of the global market in 2019.
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. Europe is expected to account for the second-largest share of the global intraoperative radiation therapy market in 2019. The growing incidence of cancer, supportive government initiatives, and the implementation of intraoperative radiation therapy market training programs & conferences/symposiums are the major factors propelling the demand for intraoperative radiation therapy market products in Europe. Furthermore, several key market players are focusing on enhancing their intraoperative radiation therapy market products to improve the quality of patient care across Europe.
Market Dynamics
Drivers- Growing Global Prevalence of Cancer
- Improving Reimbursement Scenario
- Procedural Advantages Over Ebrt
- Technological Advancements
- Dearth of Trained Personnel
- Strong Market Positioning of Alternative Therapies
- Emerging Economies Offer High Growth Potential
- Growing Applications of IORT
- Risk of Radiation Exposure
Companies Mentioned
- Ariane Medical Systems Ltd.
- Becton, Dickinson and Company
- Brainlab Ag
- Eckert & Ziegler
- Elekta Ab
- GMV Innovating Solutions
- Icad, Inc.
- Intraop Medical, Inc.
- Isoaid, LLC
- Isoray, Inc.
- Merit Medical Systems
- Panacea Medical Technologies Pvt. Ltd.
- Raysearch Laboratories
- Remedi Co., Ltd.
- S.I.T. Sordina IORT Technologies S.P.A.
- Salutaris Medical Devices
- Seedos Ltd.
- Sensus Healthcare, Inc.
- Varian Medical Systems, Inc.
- Zeiss Group
For more information about this report visit https://www.researchandmarkets.com/r/djur1k
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225005898/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
